.png){kind=small}
to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterize the Human Virome in Longitudinal, Diverse Cohorts Across the Lifespan (U54 Clinical Trial Not Allowed)
HHS-NIH11
Status:
Forecasted
June 21, 2023
Posted:
Deadline:
November 17, 2023
Funding
Program:
Award Floor:
Ceiling:
Match Required?
No
Eligibility
All
States:
Entity Types:
State governments, County governments, Independent school districts, Public & State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities, Native American tribal organizations, Nonprofits (with 501(c)(3) status), Private institutions of higher education, For profit organizations other than small businesses, Small businesses
The Office of Strategic Coordination (Common Fund) intends to publish a funding opportunity to support Virome Characterization Centers for the NIH Common Fund supported Human Virome Program (HVP). More information on the HVP can be found athttps://commonfund.nih.gov/humanvirome. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and develop their approaches. The funding opportunity is expected to be published in August 2023 with an expected application due date at least 60 days after publication. No foreign applications will be allowed. The funding opportunity will use the cooperative agreement U54 mechanism for Specialized Center--Cooperative Agreements Multi-component (Clinical Trial Not Allowed). Details of the planned funding opportunity are provided below.
Contact
Email:
Phone:
Source Type:
Federal